Skip to content
Longterm Wiki
Index
Grant·RK_Cgk_By1·Record·Profile

Grant: Institut des Sciences et Techniques, Bobo-Dioulasso — Malaria Vaccine Clinical Trial (Jean Bosco Ouedraogo) (Coefficient Giving → Institut des Sciences et Techniques, Bobo-Dioulasso)

Verdictconfirmed95%
1 check · 4/9/2026

Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Our claim

entire record
Name
Institut des Sciences et Techniques, Bobo-Dioulasso — Malaria Vaccine Clinical Trial (Jean Bosco Ouedraogo)
Amount
$631,162
Currency
USD
Date
August 2021
Notes
[Human Health and Wellbeing] Open Philanthropy recommended a grant of $631,162 over three years to the Institut des Sciences et Techniques, Bobo-Dioulasso to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxfoexpand[Human Health and Wellbeing] Open Philanthropy recommended a grant of $631,162 over three years to the Institut des Sciences et Techniques, Bobo-Dioulasso to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford. Dr. Jean Bosco Ouedraogo will serve as the Institut's principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the University Of Science Technical And Technologies De Bamako, the Institut de Recherche en Sciences de la Santé, the KEMRI Wellcome Trust Research Programme, and the Ifakara Health Institute. This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

Source evidence

1 src · 1 check
confirmed95%deterministic-row-match · 4/9/2026
Name
Institut des Sciences et Techniques, Bobo-Dioulasso — Malaria Vaccine Clinical Trial (Jean Bosco Oue…
Grantee
Institut des Sciences et Techniques, Bobo-Dioulasso
Focus Area
Human

NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Case № RK_Cgk_By1Filed 4/9/2026Confidence 95%